Inference refers to inferring “the contents of a case, pallet, or other aggregate of individual units, packages, or containers of dangerous drugs, from a unique identifier associated with the case, pallet, or other aggregate, without opening each case, pallet, or other aggregate or otherwise individually validating each unit,” according to the California State Board of Pharmacy (CA BoP).
Speakers at GS1 Connect in June shared several business reasons to standardize product identification. Health systems representatives spoke of efficiencies that standardized identification could bring in product and patient identification and tracking as well as improvements in billing, ordering, and inventory. Many spoke of the need for standards, such as the GS1 family of standards.
At ACHEMA 2012, Seidenader Maschinenbau GmbH will showcase a new inspection station that measures and evaluates stress birefringence in containers, which can help identify specific prestages of crack formation, the company reports. The station will be integrated into a Seidenader MS inspection machine for vials with a throughput of up to 24,000 containers/hour. Another system will be shown for inspecting up to 36,000 syringes per hour for particles or cosmetic defects. Feeding and orientation of the syringes is provided by a Seidenader SyWalker.
GS1 US has appointed Siobhan O’Bara as vice president, healthcare. O’Bara is now responsible for setting strategy and ensuring achievement of operating results for GS1 Healthcare US, including supporting GS1 Standards implementation initiatives
across the U.S. healthcare industry, the standards organization reported in a press release.
Janice Wortham has joined Mettler-Toledo Hi-Speed as Regional Sales Manager for Pharmaceutical Sales, bringing more than 12 years of experience in packaging machinery sales. Working in the past with Waukesha Cherry-Burrell and Cozzoli Machine Co., Wortham has focused since 2004 on serialization, track and trace, and vision inspection solutions sales for the pharmaceutical industry, working with Systech International and Seidenader Vision.
By Marie Redding
It’s increasingly difficult—even for the experts—to tell the difference between a counterfeit drug and the real thing. Consumers feel they have no sure way of knowing if they’re getting duped. They may even ingest a harmful ingredient a counterfeiter has used to make a fake pill—like highway paint, floor wax, and boric acid—according to a CBS news report.
Now in our archives is our exclusive virtual conference event that examines one of the key issues facing the Pharma and BioPharma supply chain, counterfeit drugs. Titled ‘Pharmaceutical Track & Trace and Authentication: The Fight against Fake Drugs’, the event is presented by UBM brands Pharmaceutical & Medical Packaging News, Tracking & Tracing Pharmaceutical Products, InnoPack, and Pharmapack in association with CPhI Conferences. The online format features two supplier webinars, two “exhibition halls” and a lineup of featured speakers.
A new system launched in Brazil at FCE Pharma is designed to offer a stand-alone solution to support different approaches to pharmaceutical product serialization. VisioCIT can handle either labeling or direct coding, reports Christoph Lehmann, director of Uhlmann VisioTec GmbH (www.visiotecamerica.com), which can position companies to meet Brazil’s pending rules as well as others around the world.
Covectra announces a new offering for Contract Service Providers (CSP) working in the pharmaceutical space. The company’s new CSP Serialization Gateway solution allows CSPs to simplify serialization and event data exchange between CSP sites and multiple brand owners. The turnkey solution offers CSPs the opportunity to serialize selective products for customers who may not already have a mass serialization program in place.